Equity valuation : OdontoPrev : how much is a smile worth?

Detalhes bibliográficos
Autor(a) principal: Oliveira, Pedro Miguel Costa
Data de Publicação: 2015
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.14/20028
Resumo: The aim of this master thesis is to calculate the most accurate price per share of OdontoPrev (ODPV3) on the 31st of December 2015. To perform that, a review of the related literature is carried out to realize that the Discounted Cash Flow valuation model, using the Cost of Equity as a discount rate, is the most suitable method to value the company. After discounting the free cash flows to equity, the result is a market capitalization of R$ 5,550 million, correspondent to a price per share of R$ 10.45. Besides that, the relative valuation (multiples) approach is also used to confirm the accuracy of the price per share under the discounted cash flow valuation, which displays an upside potential of 6.7% when compared with the share traded on the 28th of August 2015 – R$ 9.79. This makes it believable that OdontoPrev is being slightly undervalued by the market, making it a good opportunity to hold the investment. A “Hold” recommendation is the result of the assumptions on the future growth prospects of the company, taking into consideration that macroeconomic events occurring in emerging markets (i.e. Brazil) may have significant impact on the valuation.
id RCAP_753f263b27ef5010e0be675f54f436d3
oai_identifier_str oai:repositorio.ucp.pt:10400.14/20028
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Equity valuation : OdontoPrev : how much is a smile worth?Domínio/Área Científica::Ciências Sociais::Economia e GestãoThe aim of this master thesis is to calculate the most accurate price per share of OdontoPrev (ODPV3) on the 31st of December 2015. To perform that, a review of the related literature is carried out to realize that the Discounted Cash Flow valuation model, using the Cost of Equity as a discount rate, is the most suitable method to value the company. After discounting the free cash flows to equity, the result is a market capitalization of R$ 5,550 million, correspondent to a price per share of R$ 10.45. Besides that, the relative valuation (multiples) approach is also used to confirm the accuracy of the price per share under the discounted cash flow valuation, which displays an upside potential of 6.7% when compared with the share traded on the 28th of August 2015 – R$ 9.79. This makes it believable that OdontoPrev is being slightly undervalued by the market, making it a good opportunity to hold the investment. A “Hold” recommendation is the result of the assumptions on the future growth prospects of the company, taking into consideration that macroeconomic events occurring in emerging markets (i.e. Brazil) may have significant impact on the valuation.Martins, José Carlos TudelaVeritati - Repositório Institucional da Universidade Católica PortuguesaOliveira, Pedro Miguel Costa2016-05-02T09:55:40Z2016-02-2520152016-02-25T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10400.14/20028TID:201171821enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-12T17:25:46Zoai:repositorio.ucp.pt:10400.14/20028Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T18:16:33.021284Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Equity valuation : OdontoPrev : how much is a smile worth?
title Equity valuation : OdontoPrev : how much is a smile worth?
spellingShingle Equity valuation : OdontoPrev : how much is a smile worth?
Oliveira, Pedro Miguel Costa
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
title_short Equity valuation : OdontoPrev : how much is a smile worth?
title_full Equity valuation : OdontoPrev : how much is a smile worth?
title_fullStr Equity valuation : OdontoPrev : how much is a smile worth?
title_full_unstemmed Equity valuation : OdontoPrev : how much is a smile worth?
title_sort Equity valuation : OdontoPrev : how much is a smile worth?
author Oliveira, Pedro Miguel Costa
author_facet Oliveira, Pedro Miguel Costa
author_role author
dc.contributor.none.fl_str_mv Martins, José Carlos Tudela
Veritati - Repositório Institucional da Universidade Católica Portuguesa
dc.contributor.author.fl_str_mv Oliveira, Pedro Miguel Costa
dc.subject.por.fl_str_mv Domínio/Área Científica::Ciências Sociais::Economia e Gestão
topic Domínio/Área Científica::Ciências Sociais::Economia e Gestão
description The aim of this master thesis is to calculate the most accurate price per share of OdontoPrev (ODPV3) on the 31st of December 2015. To perform that, a review of the related literature is carried out to realize that the Discounted Cash Flow valuation model, using the Cost of Equity as a discount rate, is the most suitable method to value the company. After discounting the free cash flows to equity, the result is a market capitalization of R$ 5,550 million, correspondent to a price per share of R$ 10.45. Besides that, the relative valuation (multiples) approach is also used to confirm the accuracy of the price per share under the discounted cash flow valuation, which displays an upside potential of 6.7% when compared with the share traded on the 28th of August 2015 – R$ 9.79. This makes it believable that OdontoPrev is being slightly undervalued by the market, making it a good opportunity to hold the investment. A “Hold” recommendation is the result of the assumptions on the future growth prospects of the company, taking into consideration that macroeconomic events occurring in emerging markets (i.e. Brazil) may have significant impact on the valuation.
publishDate 2015
dc.date.none.fl_str_mv 2015
2016-05-02T09:55:40Z
2016-02-25
2016-02-25T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.14/20028
TID:201171821
url http://hdl.handle.net/10400.14/20028
identifier_str_mv TID:201171821
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131849437478912